UMMC, MOH HOSPITALS STUDYING ARTHRITIS DRUG TREATMENT FOR SEVERE COVID-19

Great news and new hope!

CIC and the UMMC Covid-19 special taskforce go full force looking for new treatment for Covid-19 patients.

“UMMC has already used tocilizumab (trade name Actemra) on several Covid-19 patients who developed “cytokine storm” syndrome, a dangerous overreaction of the immune system, resulting in respiratory and multi-organ failure and said that the results were encouraging”.

Read More

Share:

More Posts

SELAMAT HARI RAYA AIDILFITRI 1445H

  Salam Aidilfitri dari CIC! Semoga Syawal ini diberkati dengan kegembiraan dan keberkatan untuk anda dan seluruh warga keluarga. #LeaderinClinicalResearch#ClinicalInvestigationcentre#ClinicalResearchinMalaysia#ClinicalResearch

Newsletter

Scroll to Top